Bioventus's market cap is currently ―. The company's EPS TTM is $-2.511; its P/E ratio is -1.87; Bioventus is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Apr 23	Dec 22
Income Statement	-
Total Revenue	$ 135.42M	$ 120.79M	$ 137.07M	$ 119.06M	-
Gross Profit	$ 86.30M	$ 78.85M	$ 89.12M	$ 73.92M	-
EBIT	$ -8.18M	$ -7.96M	$ -4.12M	$ -90.47M	-
EBITDA	$ 4.29M	$ 5.87M	$ 10.48M	$ -88.34M	-
Net Income Common Stockholders	$ -6.10M	$ -7.30M	$ -3.68M	$ -103.99M	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 36.96M	$ 26.83M	$ 29.39M	$ 47.10M	$ 31.84M
Total Assets	$ 810.91M	$ 811.10M	$ 836.96M	$ 887.40M	$ 1.37B
Total Debt	$ 394.85M	$ 394.62M	$ 385.89M	$ 445.58M	$ 418.07M
Net Debt	$ 357.88M	$ 367.79M	$ 356.50M	$ 398.48M	$ 386.23M
Total Liabilities	$ 589.79M	$ 584.65M	$ 603.62M	$ 647.04M	$ 1.03B
Stockholders Equity	$ 173.59M	$ 177.53M	$ 183.18M	$ 188.50M	$ 316.58M
Cash Flow	-
Free Cash Flow	$ 10.01M	$ -10.35M	$ 9.40M	$ 1.10M	$ -18.18M
Operating Cash Flow	$ 10.37M	$ -8.31M	$ 10.79M	$ 4.66M	$ -14.78M
Investing Cash Flow	$ -591.00K	$ -2.04M	$ 45.01M	$ -15.07M	$ 16.62M
Financing Cash Flow	$ -14.00K	$ 8.23M	$ -62.25M	$ 27.38M	$ -5.44M

Currency in USD

Bioventus Earnings and Revenue History

Income Statement >

Bioventus Debt to Assets

Balance Sheet >

Bioventus Cash Flow

Cash Flow >

Bioventus Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing